Advanced search
Publication Cover
Pathology Volume 34, 2002 - Issue 2
Submit an article Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Gene targeting technology and advances in the pathophysiology of inflammation

D. Sean Riminton Centenary Institute for Cancer Medicine and Cell Biology, Camperdown, and Department of Immunology, Concord Hospital, Concord, NSW, Australia
Pages 109-114 | Published online: 06 Jul 2009

  • Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85: 311-8.
  • Majzouh J, Muglia L. Knockout mice. New Engl J Med 1996; 334: 904-7.
  • Galli-Taliadoros LA, Wood S A, Sedgwick JD, Körner H. Gene knockout technology: a methodological overview for the interested novice. J Immunol Methods 1995; 181: 1-15.
  • Rohertson E, Bradley A, Kuehn M, Evans M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 1986; 323: 445-8.
  • Evans M, Kauf man M. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-6.
  • Martin G. Isolation of a pluripotent cell line from early mouse embryos cultured in media conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981; 78: 7634-8.
  • Bradley A, Evans M, Kauf man M, Robertson E. Formation of germline chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984; 309: 255-6.
  • Gossler A, Doetschman T, Korn R, Serfling E, Kemler R. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc Natl Acad Sci USA 1986; 83: 9065-9.
  • Robertson EJ, Bradley A, Kuehn M, Evans M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 1986; 323: 445-8.
  • Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS. Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 1985; 317: 230-4.
  • Thomas K, Capecchi M. Site directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51: 503-12.
  • Zijlstra M, Ei E, Sajjadi F, Subramani S, Jaenisch R. Germline transmission of a disrupted beta-2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 1989; 342: 435-8.
  • Crusio W E. Gene targeting studies: new methods, old problems. Trends Neurosci 1996; 19: 186-7.
  • Wakeland E, Morel E, Achey K, Yui M, Longmate J. Speed congenics: a classic technique in the fast lane (relatively speaking) Immunol Today 1997; 18: 472-7.
  • Olson EN, Arnold H-H, Rigby PWJ, Wold BJ. Know your neighbors: three phenotypes in null mutants of the myogenic bHEH gene MRF4. Cell 1996; 85: 1-4.
  • Baubonis W, Sauer B. Genomic targeting with purified Cre recombinase. Nucleic Acids Res 1993; 21: 2025-9.
  • Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci USA 1997; 94: 9302-7.
  • Sedgwick JD, Riminton DS, Cyster JG, Korner H. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today 2000; 21: 110-3.
  • Bean A, Roach DR, Briscoe H, et al. Structural deficiencies in granuloma formation in TNF-gene targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999; 162: 3504-11.
  • Cook MC, Korner H, Riminton DS, et al. Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med 1998; 188: 1503-10.
  • Körner H, Riminton DS, Strickland DH, Eemckert FA, Pollard J, Sedgwick JD. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med 1997; 186: 1585-90.
  • Rennert P D, Browning JE, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 1996; 184: 1999-2006.
  • Matsumoto M, Fu Y-X, Molina H, Chaplin DD. Eymphotoxin-alpha-deficient and TNF receptor-1-deficient mice developmental and functional characteristics of germinal centers. Immunol Rev 1997; 156: 137-44.
  • Roach DR, Briscoe H, Saunders B, France MP, Riminton S, Britton WJ. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 2001; 193: 239-46.
  • Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor-alpha neutralizing agent. New Engl J Med 2001; 345: 1098-104.
  • Tanaka H, Kawacla N, Yaniada T, Kawacla K, Takatsu K, Nagai H. Allergen-induced airway inflammation and bronchial responsivenes s in interleukin-5 receptor alpha chain-deficient mice. Clin Exp Allergy 2000; 30: 874-81.
  • Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339-42.
  • Christ M, McCartney FN, Kulkarni AB, et al. Immune dysregulation in TGF-beta 1-deficient mice. J Immunol 1994; 153: 1936-46.
  • Lee EG, Boone DL, Chai S, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000; 289: 2350-4.
  • Ma A, Datta M, Margosian E, Chen J, Horak I. T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med 1995; 182: 1567-72.
  • Kuhn R, Lohler J, Rennick D. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-74.
  • Ermann J, Fathman CG. Autoimmune diseases: genes, hugs and failed regulation. Nat Immunol 2001; 2: 759-61.
  • Yasutomo K, Horiuchi T, Kagami S, et al Mutation in DNASEl in people with systemic lupus erythematosus. Nat Genet 2001; 28: 313-4.
  • Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000; 76: 227-324.
  • Wandstrat A, Wakeland EK. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001; 2: 802-9.
  • Kozak W, Kluger MJ, Soszynski D, et al. IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann NY Acad Sci 1998; 856: 33-47.
  • Horai R, Saijo S, Tanioka H, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin-1 receptor antagonist-deficient mice. J Exp Med 2000; 191: 313-20.
  • Ma A, Datta M, Margosian E, Chen J, Horak I. T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med 1995; 182: 1567-72.
  • Christ M, McCartney-Francis NL, Kulkarni AB, et al. Immune dysregulation in TGF-beta 1-deficient mice. J lmmunol 1994; 153: 1936-46.
  • Marino M, Dunn A, Grail D, et al. Characterisation of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997; 94: 8093-8.
  • Riminton DS, Körner H, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, hut not TNF-deficient mice. J Exp Med 1998; 187: 1517-28.
  • Körner H, Cook M, Riminton DS, et al. Distinct roles for Lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organisation of lymphoid tissue. Eur J immunol 1997; 27: 2600-9.
  • Forlow SB, White EJ, Barlow SC, et al. Severe inflammatory defect and reduced viability in CD 18 and E-selectin double-mutant mice. J Clin Invest 2000; 106: 1457-66.
  • Langenbach R, Morham SG, Tiano HF, et al. Disruption of the mouse cyclooxygenase I gene. Characteristics of the mutant and areas for future study. Adv Exp Med Biol 1997; 407: 87-92.
  • Dinchuk JE, Car BD, Focht RJ, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995; 378: 406-9.
  • Hopken UE, Eu B, Gerard NP, Gerard C. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J Exp Med 1997; 186: 749-56.
  • Gao JE, Wynn TA, Chang Y, et al. Impaired host defense, haematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor I. J Exp Med 1997; 185: 1959-68.
  • Cook DN, Chen SC, Sullivan EM, et al. Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol 2001; 21: 3159-65.
  • Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in Dnasel-deficient mice. Nat Genet 2000; 25: 177-81.
  • Sligh JE Jr, Ballantyne CM, Rich SS, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule I. Proc Nall Acad Sci USA 1993; 90: 8529-33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.